T36.6X Poisoning by, adverse effect of and underdosing of rifampicins

Name of the Condition

• Poisoning by, adverse effect of and underdosing of rifampicins

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to rifampicins. It includes cases where rifampicin exposure leads to harmful effects, unintended reactions, or insufficient therapeutic levels. Documentation should specify the nature of the event (e.g., poisoning, adverse effect, or underdosing) and encounter details.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose of rifampicins, incorrect administration, or allergic reactions. Underdosing occurs when therapeutic levels are not achieved, often due to dosing errors, non-adherence, or inadequate prescription. Adverse effects can stem from drug interactions, idiosyncratic reactions, or cumulative toxicity.

Risk Factors

• Prior history of rifampicin allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hepatotoxicity, jaundice.
• Underdosing: Persistent infection, treatment failure.

Diagnosis

Evaluation includes patient history of rifampicin use, clinical assessment of symptoms, and laboratory tests (e.g., liver function tests, drug levels). Documentation should clarify the event type (poisoning, adverse effect, or underdosing) to guide coding.

Treatment Options

Treatment depends on the event type: poisoning may require decontamination or supportive care; adverse effects may need discontinuation or symptom management; underdosing may involve dose adjustment or adherence support.

Prognosis and Follow-Up

Prognosis varies by severity. Mild cases often resolve with intervention, while severe poisoning or hepatotoxicity may require prolonged monitoring. Follow-up includes assessing treatment response and monitoring for recurrence.

Complications

• Severe hepatotoxicity or liver failure.
• Anaphylaxis or severe allergic reactions.
• Treatment failure due to underdosing.
• Drug interactions leading to toxicity.

Lifestyle & Prevention

• Educate patients on proper rifampicin use and adherence.
• Monitor for signs of adverse effects during therapy.
• Avoid concurrent use of hepatotoxic drugs when possible.
• Ensure accurate dosing and administration.

When to Seek Professional Help

Seek care for symptoms like jaundice, severe rash, difficulty breathing, or persistent infection. Immediate medical attention is needed for suspected overdose or anaphylaxis.

Tips for Medical Coders

Document the event type (poisoning, adverse effect, or underdosing) and encounter details. Specify rifampicin exposure and intent (e.g., accidental, therapeutic error) to ensure accurate coding.